Products | Lung Imaging | September 13, 2016

Vitrea CT Lung Analysis

Vitrea CT Lung Analysis

Related Content

News | Artificial Intelligence
eBook on AI's Role in Lung Cancer Diagnosis Now Available

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Computed Tomography (CT)
Bayer, Alara Imaging to Collaborate

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business
VIDEO: One on One with Reed A. Omary, MD, MS, Vanderbilt University Medical Center

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx
News | Radiopharmaceuticals and Tracers
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Professional registration is open for RSNA 2024
News | RSNA
RSNA 2024 Registration Is Open

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class III medical device license from Health Canada for all its medical imaging AI solutions according to a statement released by the company, led by co-founder and CEO, Prashant Warier.
News | Artificial Intelligence
Qure.ai Receives Class III Medical Device License Approval from Health Canada 

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
Epithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old.
News | PET-CT
Comparison of FDG-PET/CT and CT for Treatment Evaluation of Patients with Unresectable Malignant Pleural Mesothelioma

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
Guidance from preoperative magnetic resonance imaging (MRI) helps clinicians deliver more precise high dose-rate (HDR) prostate brachytherapy treatments
News | Prostate Cancer
GE HealthCare’s MIM Software Introduces MIM Symphony HDR Prostate for MR Image Guidance During Procedures

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
MD Anderson researchers demonstrate value of IMRT compared to 3D-CRT, validate heart exposure as important radiation planning objective
News | Radiation Therapy
Study Supports Precision Radiation Therapy in Lung Cancer

July 3, 2024 — Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support ...

Time July 03, 2024
arrow
Thirona, a provider of advanced lung image analysis with artificial intelligence, led by scientist now CEO Eva van Rikxoort, has recently announced multiple partnerships.
News | Artificial Intelligence
Thirona Announces Partnerships to Enhance AI-based Lung Image Analysis

June 27, 2024 — Thirona, a Netherlands-based global company providing high-precision advanced lung image analysis with ...

Time June 27, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now